샘플 요청 목록

 카트 문의
시장보고서
상품코드
1542776

세계의 관상동맥 가이드와이어 시장

Coronary Guidewires
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 174 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

관상동맥 가이드와이어 세계 시장은 2030년까지 8억 720만 달러에 달할 것으로 예상됩니다

2023년 5억 9,720만 달러로 추정되는 관상동맥 가이드와이어 세계 시장은 2023-2030년간의 분석 기간 동안 연평균 4.4% 성장하여 2030년에는 8억 720만 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 니티놀 기반 가이드와이어는 CAGR 2.9%를 기록하여 분석 기간 말에 5억 5,020만 달러에 도달할 것으로 예상됩니다. 스틸 베이스 가이드와이어 부문의 성장률은 분석 기간 동안 CAGR 8.3%로 추정됩니다.

미국 시장 1억 6,080만 달러, 중국은 CAGR 4.3%로 성장 전망

미국의 관상동맥 가이드와이어 시장은 2023년 1억 6,080만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 시장 규모가 1억 2,890만 달러에 달할 것으로 예상되며, 2023-2030년간의 분석 기간 동안 4.3%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 4.2%와 3.6%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 유럽에서는 독일이 연평균 3.7%의 성장률을 보일 것으로 예상됩니다.

세계 관상동맥 가이드와이어 시장 - 주요 동향 및 촉진요인 정리

증가하는 심장병: 전 세계적으로 확대되는 심장병 위기

심혈관계 질환(CVDs)은 전 세계적으로 심각한 속도로 증가하고 있으며, 전 세계 사망 원인 1위로 꼽히고 있습니다. 고령화, 도시화, 생활습관의 변화(건강에 해로운 음식 섭취 증가, 신체활동 감소, 담배 사용 등)가 심장질환의 확산에 크게 기여하고 있습니다. 현대인의 생활습관은 고혈압, 비만, 당뇨병과 같은 위험요인을 유발하기 쉬울 뿐만 아니라, 증가하는 심장 관련 질환을 관리하는 데 있어 의료 시스템이 직면한 문제를 더욱 악화시키고 있습니다. 매년 수백만 명의 사람들이 CVD 진단을 받고 있으며, 이러한 증가 추세를 막기 위해서는 예방 조치 강화, 보다 광범위한 공중보건 캠페인, 보다 접근하기 쉬운 치료 옵션이 시급히 필요하다는 점이 강조되고 있습니다. 각국이 자국민의 의료 수요를 충족시키기 위해 노력하는 가운데, 수백만 명의 심장 건강이 위험에 처해 있으며, 전 세계 정부와 조직은 심혈관 치료와 연구를 우선순위에 두어야 합니다.

심장의 미로 탐색 : 관상 동맥 가이드와이어는 어떻게 변화를 가져올 수 있는가?

관상동맥 가이드와이어는 심장 전문의가 혈관 성형술이나 스텐트 삽입과 같은 시술 시 심장의 복잡한 혈관 시스템을 탐색하기 위해 사용하는 가느다란 와이어입니다. 이 와이어는 카테터 및 기타 기구를 안내하는 역할을 하며, 관상동맥 질환의 증상으로 흔히 나타나는 막히거나 좁아진 동맥을 정확하게 찾아내어 치료할 수 있도록 도와줍니다. 관상동맥 가이드와이어의 유연성과 강도는 손상 없이 섬세한 혈관을 안전하게 가로질러야 하기 때문에 매우 중요합니다. 일반적으로 스테인리스 스틸 또는 니티놀 코어로 만들어진 이 와이어는 마찰을 줄이는 친수성 코팅이 적용되어 좁고 구불구불한 동맥 경로를 보다 원활하게 통과할 수 있도록 설계되어 있습니다. 이러한 정밀한 조작성은 중재적 시술의 성공에 필수적이며, 적절한 혈류를 회복하고 심장마비 위험을 줄임으로써 환자의 예후에 직접적인 영향을 미칩니다.

관상동맥 가이드와이어의 미래를 바꿀 혁신이란?

최근 관상동맥 가이드와이어의 진화는 카테터 시술의 사용 편의성과 효율성을 높이기 위한 기술 발전으로 특징지어집니다. 최신 가이드와이어는 의사가 보다 정확하게 와이어를 유도할 수 있도록 토크 제어를 강화하는 등 첨단 기능을 갖추고 있습니다. 또한, 하이브리드 가이드와이어의 개발로 와이어의 다양한 부분에 유연성 및 강성과 같은 다양한 기능을 결합하여 특정 시술의 요구와 복잡성을 충족시킬 수 있게 되었습니다. 재료 과학의 혁신은 추적성을 개선하고 혈관 외상을 감소시키는 마이크로 코팅된 표면을 가진 가이드와이어의 생산으로 이어지고 있습니다. 이러한 기술적 개선은 보다 안전하고 효율적인 시술을 가능하게 할 뿐만 아니라, 보다 복잡한 관상동맥 질환에 대한 최소침습적 시술의 가능성을 넓혀주고 있습니다.

관상동맥 가이드와이어의 사용에는 어떤 도전과 위험이 있는가?

심장 카테터 치료에서 중요한 역할에도 불구하고 관상동맥 가이드와이어의 사용에 위험과 문제가 없는 것은 아닙니다. 주요 우려 사항 중 하나는 와이어가 실수로 혈관 경로에서 벗어날 경우 발생할 수 있는 동맥 손상의 가능성입니다. 이러한 사고는 드물지만 혈관 천공 및 후속 출혈을 포함한 심각한 합병증으로 이어질 수 있습니다. 또한, 특정 시술에 적합한 가이드와이어를 선택하는 것은 환자의 관상동맥 해부학적 특성에 따라 달라지기 때문에 수술 담당 의사의 숙련도와 경험이 매우 중요합니다. 또한, 가이드와이어를 통과시키는 작업은 시간이 오래 걸리고 높은 정밀도가 필요하기 때문에 시간이 촉박한 응급 상황에서는 문제가 발생합니다. 따라서 이러한 위험을 줄이고 가이드와이어 사용의 안전성과 효율성을 높이기 위해서는 지속적인 교육과 가이드와이어 기술의 발전이 필수적입니다.

관상동맥 가이드와이어 시장의 성장 원동력은 무엇인가?

관상동맥 가이드와이어 시장의 성장은 전 세계 심혈관 질환의 유병률 증가, 관상동맥 가이드와이어의 기술 발전, 최소 침습적 시술에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 세계 인구의 고령화로 인해 죽상동맥경화증과 같은 관상동맥 질환의 유병률이 증가하고 있으며, 이로 인해 중재적 심장학 시술에 대한 필요성이 증가하고 있습니다. 또한, 가이드와이어 기술의 발전으로 시술 성공률이 높아지고 합병증이 감소함에 따라 의료 서비스 제공업체들이 이 시술을 채택하고 있습니다. 또한, 회복 시간을 단축하고 감염 위험을 줄이기 위한 최소침습적 수술이 의료 시스템과 환자들의 선호도가 높아지면서 관상동맥 가이드와이어와 같은 장비에 대한 수요도 지속적으로 증가하고 있습니다. 신흥 시장의 의료 인프라 확대와 의료비 증가와 같은 경제적 요인도 관상동맥 가이드와이어 시장 확대에 기여하고 있으며, 관상동맥 가이드와이어는 최신 심장 치료 솔루션의 중요한 구성 요소로 자리매김하고 있습니다.

조사 대상 기업 예시(총 42건)

  • Abbott Vascular
  • AMG International
  • Asahi Intecc Co.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BrosMed Medical Co.
  • Comed B.V.
  • Cordis Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Medical Technology（Beijing）Co.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Optimed Medizinische Instrumente GmbH
  • Rontis AG.
  • SP Medical A/S
  • Teleflex Inc.
  • Terumo Medical Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 24.09.04

Global Coronary Guidewires Market to Reach US$807.2 Million by 2030

The global market for Coronary Guidewires estimated at US$597.2 Million in the year 2023, is expected to reach US$807.2 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Nitinol-Based Guidewires, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$550.2 Million by the end of the analysis period. Growth in the Steel-Based Guidewires segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$160.8 Million While China is Forecast to Grow at 4.3% CAGR

The Coronary Guidewires market in the U.S. is estimated at US$160.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$128.9 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Coronary Guidewires Market - Key Trends and Drivers Summarized

Heart Trouble on the Rise: The World's Growing Cardio Crisis

The global burden of cardiovascular diseases (CVDs) is escalating at an alarming rate, making it the leading cause of death worldwide. Factors such as aging populations, urbanization, and lifestyle changes—including increased consumption of unhealthy foods, reduced physical activity, and tobacco use—contribute significantly to the prevalence of heart diseases. Modern lifestyles not only predispose individuals to risk factors like hypertension, obesity, and diabetes but also exacerbate the challenges healthcare systems face in managing the rising tide of heart-related ailments. Each year, millions of people are diagnosed with CVDs, stressing the urgent need for enhanced preventive measures, broader public health campaigns, and more accessible treatment options to stem the tide of this growing epidemic. As countries grapple with the healthcare demands of their populations, the heart health of millions hangs in the balance, pressing governments and organizations worldwide to prioritize cardiovascular care and research.

Navigating the Heart's Labyrinths: How Do Coronary Guidewires Make a Difference?

Coronary guidewires are slender wires used by cardiologists to navigate through the complex vascular system of the heart during procedures such as angioplasty or stent placements. These wires act as a guide for catheters and other devices, allowing for accurate positioning and delivery of treatment to blocked or narrowed arteries, which are often symptoms of coronary artery disease. The flexibility and strength of coronary guidewires are critical, as they must safely traverse delicate blood vessels without causing damage. Typically made from a core of stainless steel or nitinol, these wires are engineered with a hydrophilic coating that reduces friction, enabling smoother navigation through tight and tortuous arterial pathways. This precise maneuverability is essential for the success of interventional procedures, directly impacting patient outcomes by restoring proper blood flow and reducing the risk of heart attacks.

What Innovations Are Shaping the Future of Coronary Guidewires?

The evolution of coronary guidewires over recent years has been marked by significant technological advancements aimed at enhancing their usability and effectiveness in catheter-based procedures. Modern guidewires offer advanced features such as enhanced torque control, which allows physicians to direct the wire more precisely. Additionally, the development of hybrid guidewires, which combine different features such as flexibility and stiffness in various sections of the wire, cater to specific procedural needs and complexities. Innovations in material science have also led to the production of guidewires with micro-coated surfaces that improve trackability and reduce vascular trauma. These technological enhancements not only refine the procedure by making it safer and more efficient but also expand the potential of minimally invasive techniques in treating more complex cases of coronary artery disease.

What Challenges and Risks Are Associated with the Use of Coronary Guidewires?

Despite their pivotal role in cardiac catheterization, the use of coronary guidewires is not without risks and challenges. One of the primary concerns is the potential for arterial damage, which can occur if the wire accidentally exits the vascular pathway. Such incidents, though rare, can lead to serious complications, including blood vessel perforation and subsequent bleeding. Additionally, the selection of an appropriate guidewire for a specific procedure requires significant skill and experience from the operating physician, as the choice depends heavily on the anatomical challenges of the patient’s coronary arteries. The process of threading the guidewire can also be time-consuming and requires a high level of precision, posing challenges in emergency situations where time is critical. Therefore, continuous training and advancements in guidewire technology are crucial to mitigate these risks and enhance the safety and efficacy of their use.

What Drives the Growth in the Coronary Guidewires Market?

The growth in the coronary guidewires market is driven by several factors, including the rising prevalence of cardiovascular diseases globally, technological advancements in coronary guidewires, and the increasing demand for minimally invasive procedures. As the global population ages, the incidence of coronary artery diseases such as atherosclerosis rises, subsequently increasing the need for interventional cardiology procedures. The advancements in guidewire technology that offer greater procedural success rates and reduced complications are also encouraging their adoption among healthcare providers. Additionally, as healthcare systems and patients increasingly prefer minimally invasive surgeries for their shorter recovery times and lower infection risks, the demand for devices such as coronary guidewires that facilitate these procedures continues to grow. Economic factors such as expanding healthcare infrastructure in emerging markets and increased healthcare spending also contribute to the expansion of the coronary guidewires market, ensuring it remains a vital component of modern cardiac care solutions.

Select Competitors (Total 42 Featured) -

  • Abbott Vascular
  • AMG International
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Comed B.V.
  • Cordis Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Optimed Medizinische Instrumente GmbH
  • Rontis AG.
  • SP Medical A/S
  • Teleflex Inc.
  • Terumo Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Coronary Guidewires - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Minimally Invasive Cardiac Procedures Drive Demand for Coronary Guidewires
    • Rising Global Prevalence of Coronary Artery Disease Spurs Market Growth
    • Increased Healthcare Spending in Emerging Markets Propels Guidewire Adoption
    • Aging Population Worldwide Sustains Growth in Coronary Intervention Procedures
    • Insurance Coverage Impact Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Coronary Guidewires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Coronary Guidewires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Coronary Guidewires by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Nitinol-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Nitinol-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Nitinol-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Steel-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Steel-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Steel-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cath Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Coronary Guidewires Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Coronary Guidewires by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Coronary Guidewires by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Coronary Guidewires by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제